|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,090 ILa | +8.57% |
|
+8.24% | -5.13% |
| 05-09 | Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating | MT |
| 05-09 | HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating | MT |
BrainsWay Ltd. reiterated revenue guidance for the year 2024. The company is reiterating previously provided full-year 2024 revenue guidance of $37 million to $40 million. This would represent growth of 16% to 26% over full-year 2023 revenue.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.13% | 90.2M | |
| +4.56% | 217B | |
| +8.86% | 190B | |
| +19.99% | 141B | |
| +30.19% | 110B | |
| +1.63% | 64.8B | |
| +16.14% | 52.44B | |
| +3.01% | 49.94B | |
| -3.97% | 42.63B | |
| +0.31% | 35.81B |
BRAINSWAY LTD. 
